Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Diagnosis × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Prostatic Neoplasms 1 Neoplasms 1 Disease 1

Interventions

pembrolizumab 54 Carboplatin 41 Docetaxel 30 Pemetrexed 29 Paclitaxel 29 Cisplatin 26 Nivolumab 22 Gemcitabine 21 Erlotinib Hydrochloride 19 Bevacizumab 16 Ipilimumab 10 osimertinib 9 atezolizumab 9 Radiosurgery 9 Drug Therapy 9 Cyclophosphamide 9 Cetuximab 9 Radiotherapy 8 Blood Specimen Collection 8 durvalumab 7 budigalimab 7 Dexamethasone 7 trametinib 6 fludarabine 6 cemiplimab 6 Taxes 6 Fluorouracil 6 130-nm albumin-bound paclitaxel 6 rovalpituzumab tesirine 5 avelumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03645018 2018-09-14

SOS2

Ospedale Santa Croce-Carle Cuneo

Phase 3 Completed

Disease, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡